Engineered Phagemids for Nonlytic, Targeted Antibacterial Therapies

Krom, Russell J; Bhargava, Prerna; Lobritz, Michael A; Collins, James J

doi:10.1021/acs.nanolett.5b01943

Type

Journal article

Permalink

https://hdl.handle.net/10161/26661

Published Version (Please cite this version)

10.1021/acs.nanolett.5b01943

Publication Info

Krom, Russell J; Bhargava, Prerna; Lobritz, Michael A; & Collins, James J (2015). Engineered Phagemids for Nonlytic, Targeted Antibacterial Therapies. Nano Letters, 15(7). pp. 4808-4813. 10.1021/acs.nanolett.5b01943. Retrieved from https://hdl.handle.net/10161/26661.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Collections

Scholarly Articles

More Info

Show full item record

Scholars@Duke

Russell-John Krom

Assistant Professor of Anesthesiology

RJ Krom is an Assistant Professor of Anesthesiology with a special interest in Liver Transplant Anesthesia and Critical Care Medicine. His research interests include establishing an ERAS pathway for liver transplant patients, regional analgesia for liver transplants, and vasoplegia in the liver transplant and ICU population.

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy

Rights for Collection: Scholarly Articles

Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info